Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) 3-Year EBITDA Growth Rate : -14.60% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Guangzhou Kingmed Diagnostics Group Co 3-Year EBITDA Growth Rate?

Guangzhou Kingmed Diagnostics Group Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.01.

During the past 12 months, Guangzhou Kingmed Diagnostics Group Co's average EBITDA Per Share Growth Rate was -77.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -14.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 29.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Guangzhou Kingmed Diagnostics Group Co was 75.50% per year. The lowest was -14.60% per year. And the median was 38.75% per year.

Competitive Comparison of Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Guangzhou Kingmed Diagnostics Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Guangzhou Kingmed Diagnostics Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Guangzhou Kingmed Diagnostics Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Kingmed Diagnostics Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangzhou Kingmed Diagnostics Group Co Ltd (SHSE:603882) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.kingmed.com.cn

Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2023, KingMed has 49 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.

Executives

Hao Bi Xi	Directors, senior managers
Wang Ling Lai	Director
Yu Shi Hui	senior management
Liang Yao Ming	Director
Peng Yong Xiang	Director

Guangzhou Kingmed Diagnostics Group Co Headlines

No Headlines